Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Svetlana Andrianova"'
Autor:
Joel W. Neal, MD, PhD, Armando Santoro, MD, Maria Gonzalez-Cao, MD, PhD, Farah Louise Lim, MRCP, MD, Bruno Fang, MD, Ryan D. Gentzler, MD, MS, Jerome Goldschmidt, MD, Polina Khrizman, MD, Claudia Proto, MD, Shiven Patel, MD, MBA, FACP, Sonam Puri, MD, Stephen V. Liu, MD, Erminia Massarelli, MD, PhD, MS, Denise Williamson, MPH, Martin Schwickart, PhD, Christian Scheffold, MD, PhD, Svetlana Andrianova, MD, MPH, Enriqueta Felip, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 10, Pp 100666- (2024)
Introduction: We evaluated efficacy and safety of cabozantinib plus atezolizumab or cabozantinib alone in advanced NSCLC previously treated with an immune checkpoint inhibitor (ICI). Methods: COSMIC-021 (NCT03170960) is a phase 1b, multicenter study
Externí odkaz:
https://doaj.org/article/6812448f29344fa6a786793805d199c0
Autor:
Daneng Li, Yohann Loriot, Adam M. Burgoyne, James M. Cleary, Armando Santoro, Daniel Lin, Santiago Ponce Aix, Ignacio Garrido-Laguna, Ramu Sudhagoni, Xiang Guo, Svetlana Andrianova, Scott Paulson
Publikováno v:
EClinicalMedicine, Vol 67, Iss , Pp 102376- (2024)
Summary: Background: Cabozantinib is approved for previously treated advanced hepatocellular carcinoma (aHCC) and has been investigated in gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJ). Atezolizumab plus bevacizumab is approv
Externí odkaz:
https://doaj.org/article/4755d3d913804c63b46661b4dce5ecba
Autor:
Sylvie Rottey, Armando Santoro, Suzanne Arnold, Saad Khan, Allen Cohn, Bruno Fang, Svetlana Andrianova, Ramu Sudhagoni, Leleesha Samaraweera, Maria Gonzalez-Cao
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Amita Patnaik, Minal Barve, Manali Bhave, Vivek Subbiah, Drew Rasco, Aarohi Bhatt, Jing Li, Svetlana Andrianova, Geoffrey Shapiro
Publikováno v:
Cancer Research. 83:P4-01
Background: Cyclin-dependent kinase 7 (CDK7) plays a significant role in the cell cycle via activation of CDKs 1, 2, 4, and 6, and regulates transcription via phosphorylation of RNA polymerase II and the estrogen receptor. CDK7 overexpression has bee
Publikováno v:
Comparative Economic Studies. 60:54-68
The paper puts forward three interrelated reasons that account for the recent breakdown of the finance–growth nexus, comprising the use (or abuse) of the relationship by policymakers, capture by ruling elites and institutional constraints. Evidence
Publikováno v:
Revue d'économie financière. :107-120
Cet article met en evidence trois facteurs interdependants pouvant expliquer la recente rupture du lien entre le financement par les banques et la croissance, a savoir l'exploitation (parfois abusive) de ce lien par les responsables politiques, la ca
Publikováno v:
Economica. 79:449-469
We put forward a modern version of the ‘developmental’ view of government-owned banks which shows that the combination of information asymmetries and weak institutions creates scope for such banks to play a growth-promoting role. We present new c
Autor:
Svetlana Andrianova, Badi Baltagi, Thorsten Beck, Panicos Demetriades, David Fielding, Stephen Hall, Steven Koch, Robert Lensink, Johan Rewilak, Peter Rousseau
We present a new database on financial fragility for 124 countries over 1998 to 2012. In addition to commercial banks, our database incorporates investment banks and real estate and mortgage banks, which are thought to have played a central role in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5a9974c930f96b72d3186757e85c74aa
http://www.up.ac.za/media/shared/61/WP/wp_2015_57.zp64619.pdf
http://www.up.ac.za/media/shared/61/WP/wp_2015_57.zp64619.pdf
Autor:
Svetlana Andrianova
Publikováno v:
Economics Letters. 83:77-82
In a simple two-sector model of economic exchange it is shown that decentralisation may fail to be Pareto-improving if traders' perception of formal contract enforcement falls short of its actual quality.
Autor:
Svetlana Andrianova
Publikováno v:
Economics Letters. 116:86-88
Weak institutions are shown to create scope for public banks to play a positive role, even if such banks are less efficient than private banks.